ERASCA INC. - COMMON STOCK
2.5400
04-October-24 15:59:59
15 minutes delayed
Stocks
+0.0900
+3.67%
Today's range
2.4600 - 2.5500
ISIN
N/A
Source
NASDAQ
-
20 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
13 Dec 2022 08:00:02 By Nasdaq GlobeNewswire
-
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib
09 Dec 2022 07:34:39 By Nasdaq GlobeNewswire
-
Erasca Announces Pricing of Underwritten Offering of Common Stock
09 Dec 2022 07:32:35 By Nasdaq GlobeNewswire
-
30 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca to Present at Upcoming Investor Conferences
22 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca Reports Third Quarter 2022 Financial Results and Business Updates
09 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
20 Oct 2022 08:00:02 By Nasdaq GlobeNewswire
-
Erasca Announces Four Poster Presentations at the Upcoming 34th EORTC-NCI-AACR Symposium
12 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022
26 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
Erasca to Present at the Morgan Stanley Global Healthcare Conference
09 Sep 2022 08:31:53 By Nasdaq GlobeNewswire
-
07 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
24 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
23 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca Reports Second Quarter 2022 Financial Results and Business Updates
11 Aug 2022 16:05:04 By Nasdaq GlobeNewswire
-
18 Jul 2022 08:00:00 By Nasdaq GlobeNewswire
-
Erasca to Present at the 2022 Jefferies Healthcare Conference
03 Jun 2022 09:00:00 By Nasdaq GlobeNewswire
-
02 Jun 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca Strengthens Clinical and Commercial Leadership with Three Key Appointments
25 May 2022 08:00:01 By Nasdaq GlobeNewswire
-
Erasca Reports First Quarter 2022 Financial Results and Business Updates
12 May 2022 16:01:00 By Nasdaq GlobeNewswire